(From Agence France Presse)
The South African arm of GlaxoSmithKline, which has been rapped for inflating prices of its AIDS drugs, said it would allow a second manufacturer to produce generic versions of its antiretroviral (ARV) medicines.
The move will lead to a significant drop in AIDS drug prices, a top official of an independent competition watchdog said Wednesday.
The company also agreed to entertain applications from two more generic manufacturers, a company statement said, according to the SAPA news agency.
GlaxoSmithKline "has... agreed to entertain applications for a further two possible licences," the SAPA news agency quoted a …